SE9904723D0 - New modulators of dopamine neurotransmission II - Google Patents
New modulators of dopamine neurotransmission IIInfo
- Publication number
- SE9904723D0 SE9904723D0 SE9904723A SE9904723A SE9904723D0 SE 9904723 D0 SE9904723 D0 SE 9904723D0 SE 9904723 A SE9904723 A SE 9904723A SE 9904723 A SE9904723 A SE 9904723A SE 9904723 D0 SE9904723 D0 SE 9904723D0
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- furane
- tetrahydrofurane
- thiophene
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Priority Applications (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904723A SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | New modulators of dopamine neurotransmission II |
RU2002119417/04A RU2262504C2 (ru) | 1999-12-22 | 2000-12-22 | Замещенные 4-(фенил-n-алкил)пиперидины, фармацевтическая композиция на их основе и способы лечения |
DE60039131T DE60039131D1 (de) | 1999-12-22 | 2000-12-22 | 4-Phenylpiperidin-Derivate als Modulatoren der Dopamin-Neurotransmission |
CNB008182582A CN1196680C (zh) | 1999-12-22 | 2000-12-22 | 新的多巴胺神经传递调节剂 |
BR0016635-9A BR0016635A (pt) | 1999-12-22 | 2000-12-22 | Moduladores de neurotransmissão de dopamina |
JP2001547057A JP5096654B2 (ja) | 1999-12-22 | 2000-12-22 | ドーパミン神経伝達の新規のモジュレーター |
EP03027034A EP1419773B1 (en) | 1999-12-22 | 2000-12-22 | 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission |
CA002394606A CA2394606C (en) | 1999-12-22 | 2000-12-22 | New modulators of dopamine neurotransmission |
HU0203874A HUP0203874A3 (en) | 1999-12-22 | 2000-12-22 | Substituted 4-(phenyl-n-alkyl)-piperazine and piperidine derivatives and their use modulators of dopamine neutransmission and pharmaceutical compositions as containing them |
EEP200200345A EE05083B1 (et) | 1999-12-22 | 2000-12-22 | Dopamiini neurotransmissiooni modulaatorid, nendekasutamine ja neid hendeid sisaldavad farmatseutilised kompositsioonid |
MXPA02006317A MXPA02006317A (es) | 1999-12-22 | 2000-12-22 | Nuevos moduladores de neurotransmision de dopamina. |
NZ519566A NZ519566A (en) | 1999-12-22 | 2000-12-22 | 3-Substituted 4-phenyl-piperazine or piperidine derivatives useful as modulators of dopamine neurotransmission |
SK866-2002A SK287366B6 (sk) | 1999-12-22 | 2000-12-22 | Modulátory neurotransmisie dopamínu |
DK03027034T DK1419773T3 (da) | 1999-12-22 | 2000-12-22 | 4-Phenylpiperidinderivativer som modulatorer af dopaminneurotransmission |
KR1020027008066A KR100771287B1 (ko) | 1999-12-22 | 2000-12-22 | 도파민 신경전달 조절제 |
US11/904,013 USRE41315E1 (en) | 1999-12-22 | 2000-12-22 | Modulators of dopamine neurotransmission |
NZ531643A NZ531643A (en) | 1999-12-22 | 2000-12-22 | 3-Substituted 4-phenyl-piperazine or piperidine derivatives useful as modulators of dopamine neurotransmission |
PCT/SE2000/002675 WO2001046146A1 (en) | 1999-12-22 | 2000-12-22 | New modulators of dopamine neurotransmission |
PT03027034T PT1419773E (pt) | 1999-12-22 | 2000-12-22 | Derivados de 4-fenilpiperidina como moduladores da neurotransmissão de dopamina |
AU25706/01A AU778183B2 (en) | 1999-12-22 | 2000-12-22 | New modulators of dopamine neurotransmission |
IL15035000A IL150350A0 (en) | 1999-12-22 | 2000-12-22 | New modulators of dopamine neurotransmission |
PL362251A PL205092B1 (pl) | 1999-12-22 | 2000-12-22 | Podstawione 4-(fenylo-N-alkilo)piperydyny, zawierające je kompozycje farmaceutyczne i ich zastosowanie |
US10/168,019 US6924374B2 (en) | 1999-12-22 | 2000-12-22 | Modulators of dopamine neurotransmission |
UA2002076054A UA73337C2 (en) | 1999-12-22 | 2000-12-22 | Dopamine neurotransmission modulators |
ES03027034T ES2307861T3 (es) | 1999-12-22 | 2000-12-22 | Derivados de 4-fenilpiperidina como moduladores de la neurotransmision de dopamina. |
AT03027034T ATE397446T1 (de) | 1999-12-22 | 2000-12-22 | 4-phenylpiperidin-derivate als modulatoren der dopamin-neurotransmission |
EP00989163A EP1240143A1 (en) | 1999-12-22 | 2000-12-22 | New modulators of dopamine neurotransmission |
CZ20022074A CZ302907B6 (cs) | 1999-12-22 | 2000-12-22 | Substituovaná (4-fenyl-N-alkyl)piperidinová sloucenina, její použití a farmaceutická kompozice s jejím obsahem |
ZA200204813A ZA200204813B (en) | 1999-12-22 | 2002-06-14 | New modulators of dopamine neurotransmission. |
NO20022879A NO323329B1 (no) | 1999-12-22 | 2002-06-17 | Substituerte 4-(fenyl-N-alkyl)-piperidin-forbindelser samt farmasoytiske materialer og anvendelser derav |
BG106845A BG65698B1 (bg) | 1999-12-22 | 2002-06-19 | Заместени 4-(фенил-n-алкил)-пиперидинови съединения, фармацевтичен състав и използването им в медицината |
IL150350A IL150350A (en) | 1999-12-22 | 2002-06-20 | New modulators of dopamine neurotransmission |
HR20020539A HRP20020539B1 (en) | 1999-12-22 | 2002-06-20 | New modulators of dopamine neurotransmission |
HK03106410.6A HK1054228B (zh) | 1999-12-22 | 2003-09-09 | 新的多巴胺神經傳遞調節劑 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904723A SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | New modulators of dopamine neurotransmission II |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9904723D0 true SE9904723D0 (sv) | 1999-12-22 |
Family
ID=20418252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904723A SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | New modulators of dopamine neurotransmission II |
Country Status (30)
Country | Link |
---|---|
US (2) | USRE41315E1 (sv) |
EP (2) | EP1240143A1 (sv) |
JP (1) | JP5096654B2 (sv) |
KR (1) | KR100771287B1 (sv) |
CN (1) | CN1196680C (sv) |
AT (1) | ATE397446T1 (sv) |
AU (1) | AU778183B2 (sv) |
BG (1) | BG65698B1 (sv) |
BR (1) | BR0016635A (sv) |
CA (1) | CA2394606C (sv) |
CZ (1) | CZ302907B6 (sv) |
DE (1) | DE60039131D1 (sv) |
DK (1) | DK1419773T3 (sv) |
EE (1) | EE05083B1 (sv) |
ES (1) | ES2307861T3 (sv) |
HK (1) | HK1054228B (sv) |
HR (1) | HRP20020539B1 (sv) |
HU (1) | HUP0203874A3 (sv) |
IL (2) | IL150350A0 (sv) |
MX (1) | MXPA02006317A (sv) |
NO (1) | NO323329B1 (sv) |
NZ (2) | NZ519566A (sv) |
PL (1) | PL205092B1 (sv) |
PT (1) | PT1419773E (sv) |
RU (1) | RU2262504C2 (sv) |
SE (1) | SE9904723D0 (sv) |
SK (1) | SK287366B6 (sv) |
UA (1) | UA73337C2 (sv) |
WO (1) | WO2001046146A1 (sv) |
ZA (1) | ZA200204813B (sv) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9904724D0 (sv) * | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
EP1638939A2 (en) * | 2003-06-24 | 2006-03-29 | Neurosearch A/S | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
DE10361259A1 (de) * | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes |
US7851629B2 (en) | 2004-06-08 | 2010-12-14 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
SE0401464D0 (sv) * | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
MXPA06013944A (es) * | 2004-06-08 | 2007-10-08 | Neurosearch Sweden Ab | Nuevas fenilpiperidinas/piperazinas disustituidas como moduladores de la neurotransmision de dopamina. |
SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
JP2008501748A (ja) * | 2004-06-08 | 2008-01-24 | ニューロサーチ スウェーデン アクチボラゲット | ドーパミン神経伝達のモジュレーターとしての新規な置換されたピペリジン |
CA2569840C (en) | 2004-06-08 | 2012-04-17 | A. Carlsson Research Ab | New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
CA2570064A1 (en) * | 2004-06-18 | 2005-12-29 | Neurosearch A/S | Novel alkyl substituted piperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
NZ555094A (en) | 2004-10-13 | 2009-07-31 | Nsab Af Neurosearch Sweden Ab | Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
MX2007004216A (es) * | 2004-10-13 | 2007-10-10 | Neurosearch Sweden Ab | Proceso para la sintesis de 4-(3-sulfonil)-piperidinas. |
ITMI20051193A1 (it) * | 2005-06-24 | 2006-12-25 | Acraf | Uso farmaceutico di una 1-3-clorofenil-3-alchilpiperazina |
SE529246C2 (sv) * | 2005-10-13 | 2007-06-12 | Neurosearch Sweden Ab | Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission |
EP1963268B1 (en) | 2005-12-07 | 2010-12-01 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission |
EP2146961B1 (en) * | 2007-04-12 | 2014-01-29 | IVAX International GmbH | N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles |
MX2009012787A (es) | 2007-06-05 | 2009-12-15 | Nsab Af Neurosearch Sweden Ab | Nuevas fenilpirrolidinas disustituidas como moduladores de neurotransmision catecolaminergica cortical. |
CN101711234A (zh) | 2007-06-05 | 2010-05-19 | Nsab神经研究瑞典公司分公司 | 作为皮层儿茶酚胺能神经传递调节剂的新型二取代的苯基吡咯烷 |
CN102036976B (zh) * | 2008-04-29 | 2013-05-01 | Nsab神经研究瑞典公司分公司 | 多巴胺神经传递的调节剂 |
US20110105462A1 (en) * | 2008-04-29 | 2011-05-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
AU2009242095A1 (en) * | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
WO2011107583A1 (en) | 2010-03-04 | 2011-09-09 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders |
WO2012028635A1 (en) | 2010-09-03 | 2012-03-08 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Deuterated analogs of pridopidine useful as dopaminergic stabilizers |
AU2012306386B2 (en) | 2011-09-07 | 2017-06-15 | Teva Pharmaceuticals International Gmbh | Polymorphic form of pridopidine hydrochloride |
EP2787997A4 (en) | 2011-12-08 | 2015-05-27 | Ivax Int Gmbh | HYDROBROMIDE SALT OF PRIDOPIDINE |
EA027748B1 (ru) | 2012-04-04 | 2017-08-31 | Тева Фармасьютикалз Интернэшнл Гмбх | Применение придопидина в комбинации с тетрабеназином для лечения двигательных нарушений и ожирения |
AR105434A1 (es) | 2015-07-22 | 2017-10-04 | Teva Pharmaceuticals Int Gmbh | Proceso para preparar pridopidina |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2027703A (en) * | 1934-06-21 | 1936-01-14 | Ribar Peter | Shoe jack |
DE1019308B (de) * | 1954-07-19 | 1957-11-14 | Hoechst Ag | Verfahren zur Herstellung gegen Bilharzia-Infektionen wirksamer 4-Phenyl-piperazine |
GB850662A (en) | 1956-10-22 | 1960-10-05 | Parke Davis & Co | Substituted piperazines and processes for their production |
BE662455A (sv) | 1964-04-14 | |||
GB1060160A (en) | 1964-08-05 | 1967-03-01 | Allen & Hanburys Ltd | 4-phenylpiperidine derivatives |
NL6607959A (sv) * | 1965-06-10 | 1966-12-12 | ||
US3539573A (en) | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
CA1061356A (en) * | 1975-10-03 | 1979-08-28 | Dieter H. Klaubert | 2-cyano-3- or 4-(substituted amino) oxanilic acid derivatives |
GB1560271A (en) | 1977-01-14 | 1980-02-06 | Joullie International Sa | Therapeutically useful m-trifluoromethylphenylpiperazine derivatives |
US4202898A (en) * | 1978-06-05 | 1980-05-13 | Synthelabo | Method of treating anxiety and depression |
FR2459797A2 (fr) | 1978-08-01 | 1981-01-16 | Synthelabo | Derives de phenyl-1 piperazine et leur application en therapeutique |
US4267328A (en) | 1978-08-01 | 1981-05-12 | Synthelabo | 1-Phenylpiperazines |
US4333942A (en) | 1979-08-03 | 1982-06-08 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Anti-depressant and analgesic 4-phenoxypiperidines |
JPS5714585A (en) * | 1980-06-30 | 1982-01-25 | Taiho Yakuhin Kogyo Kk | 1-cycloalkylmethylpiperazine derivative |
US4518712A (en) | 1980-06-30 | 1985-05-21 | Taiho Pharmaceutical Company Limited | Piperazine derivative and analgesic composition containing the same |
GB2083476B (en) * | 1980-09-12 | 1984-02-08 | Wyeth John & Brother Ltd | Heterocyclic compounds |
FR2501506A1 (fr) | 1981-03-11 | 1982-09-17 | Sanofi Sa | Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine |
JPS5815979A (ja) * | 1981-07-11 | 1983-01-29 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体およびその製造法 |
US4415736A (en) | 1981-12-28 | 1983-11-15 | E. I. Du Pont De Nemours & Co. | Certain tetrahydropyridine intermediates |
EP0094159B1 (en) | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dihydropyridine derivatives, their production and use |
US4504660A (en) | 1982-07-06 | 1985-03-12 | American Home Products Corporation | Process for the production of 2,6-diaminobenzonitrile derivatives |
ES540226A0 (es) * | 1985-02-07 | 1985-12-01 | Inst Investigacion Desarrollo | Un nuevo procedimiento de obtencion de derivados del acido quinolincarboxilico |
US4892975A (en) | 1987-09-28 | 1990-01-09 | President And Fellows Of Harvard College | Diethynyl monomers and polymers thereof |
HU198454B (en) | 1987-12-14 | 1989-10-30 | Richter Gedeon Vegyeszet | Process for production of new derivatives of tetrahydrospiridin and medical compositions containing these compounds |
FR2639226B1 (fr) | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
AU658134B2 (en) * | 1989-12-28 | 1995-04-06 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
KR100196888B1 (ko) | 1991-04-17 | 1999-06-15 | 파마시아 앤드 업죤 컴패니 | 중추 작용성을 갖는 신규한 치환된 페닐아자사이클로 알칸 |
AU676993B2 (en) | 1991-06-27 | 1997-04-10 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
NZ240863A (en) | 1991-09-11 | 1995-04-27 | Mcneilab Inc | Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof |
GB9119920D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
GB9119932D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
DE69232003T2 (de) | 1991-09-18 | 2002-04-25 | Glaxo Group Ltd | Benzanilidderivate als 5-HT1D-Antagonisten |
TW240217B (sv) * | 1992-12-30 | 1995-02-11 | Glaxo Group Ltd | |
GB2276160A (en) * | 1993-03-17 | 1994-09-21 | Glaxo Group Ltd | Ethanone compounds. |
US5502050A (en) * | 1993-11-29 | 1996-03-26 | Cornell Research Foundation, Inc. | Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
EP0659743A1 (en) | 1993-12-27 | 1995-06-28 | Hoechst Aktiengesellschaft | Piperidine derivatives as inhibitors of platelet aggregation and their preparation |
CA2144669A1 (en) | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Biphenyl derivatives |
US5571822A (en) * | 1994-09-30 | 1996-11-05 | The University Of North Carolina At Chapel Hill | Antitumor compounds |
WO1997003986A1 (fr) | 1995-07-19 | 1997-02-06 | Yoshitomi Pharmaceutical Industries, Ltd. | Composes fusionnes de triazole |
FR2740134B1 (fr) * | 1995-10-18 | 1998-01-09 | Pf Medicament | Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant |
US5892041A (en) | 1996-08-12 | 1999-04-06 | Neurogen Corporation | Fused indolecarboxamides: dopamine receptor subtype specific ligands |
DE19637237A1 (de) | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
US6232326B1 (en) | 1998-07-14 | 2001-05-15 | Jodi A. Nelson | Treatment for schizophrenia and other dopamine system dysfunctions |
JP2000086603A (ja) | 1998-07-15 | 2000-03-28 | Yoshitomi Pharmaceut Ind Ltd | 桂皮酸アミド誘導体および3―フェニルプロピオン酸アミド誘導体 |
IL146403A0 (en) | 1999-06-22 | 2002-07-25 | Neurosearch As | Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
SE9904724D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
US6906120B1 (en) | 2000-06-20 | 2005-06-14 | General Electric | Poly(arylene ether) adhesive compositions |
WO2002005819A1 (en) * | 2000-07-15 | 2002-01-24 | Smithkline Beecham Corporation | Compounds and methods |
CA2432985A1 (en) | 2001-01-23 | 2002-08-01 | Vincent Mancuso | Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
US6663587B2 (en) * | 2001-06-22 | 2003-12-16 | Medela Holding Ag | Breastshield with multi-pressure and expansible chamber construction, related breastpump and method |
US20050004164A1 (en) | 2003-04-30 | 2005-01-06 | Caggiano Thomas J. | 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
US7851629B2 (en) | 2004-06-08 | 2010-12-14 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
MXPA06013944A (es) | 2004-06-08 | 2007-10-08 | Neurosearch Sweden Ab | Nuevas fenilpiperidinas/piperazinas disustituidas como moduladores de la neurotransmision de dopamina. |
SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
CA2569840C (en) | 2004-06-08 | 2012-04-17 | A. Carlsson Research Ab | New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
SE529246C2 (sv) | 2005-10-13 | 2007-06-12 | Neurosearch Sweden Ab | Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission |
EP1963268B1 (en) | 2005-12-07 | 2010-12-01 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission |
-
1999
- 1999-12-22 SE SE9904723A patent/SE9904723D0/sv unknown
-
2000
- 2000-12-22 BR BR0016635-9A patent/BR0016635A/pt not_active IP Right Cessation
- 2000-12-22 PL PL362251A patent/PL205092B1/pl not_active IP Right Cessation
- 2000-12-22 JP JP2001547057A patent/JP5096654B2/ja not_active Expired - Fee Related
- 2000-12-22 CN CNB008182582A patent/CN1196680C/zh not_active Expired - Fee Related
- 2000-12-22 CA CA002394606A patent/CA2394606C/en not_active Expired - Fee Related
- 2000-12-22 ES ES03027034T patent/ES2307861T3/es not_active Expired - Lifetime
- 2000-12-22 AU AU25706/01A patent/AU778183B2/en not_active Ceased
- 2000-12-22 UA UA2002076054A patent/UA73337C2/uk unknown
- 2000-12-22 DK DK03027034T patent/DK1419773T3/da active
- 2000-12-22 HU HU0203874A patent/HUP0203874A3/hu unknown
- 2000-12-22 SK SK866-2002A patent/SK287366B6/sk not_active IP Right Cessation
- 2000-12-22 EE EEP200200345A patent/EE05083B1/xx not_active IP Right Cessation
- 2000-12-22 EP EP00989163A patent/EP1240143A1/en not_active Withdrawn
- 2000-12-22 AT AT03027034T patent/ATE397446T1/de active
- 2000-12-22 NZ NZ519566A patent/NZ519566A/en unknown
- 2000-12-22 WO PCT/SE2000/002675 patent/WO2001046146A1/en not_active Application Discontinuation
- 2000-12-22 PT PT03027034T patent/PT1419773E/pt unknown
- 2000-12-22 RU RU2002119417/04A patent/RU2262504C2/ru not_active IP Right Cessation
- 2000-12-22 CZ CZ20022074A patent/CZ302907B6/cs not_active IP Right Cessation
- 2000-12-22 US US11/904,013 patent/USRE41315E1/en not_active Expired - Lifetime
- 2000-12-22 DE DE60039131T patent/DE60039131D1/de not_active Expired - Lifetime
- 2000-12-22 US US10/168,019 patent/US6924374B2/en not_active Ceased
- 2000-12-22 MX MXPA02006317A patent/MXPA02006317A/es active IP Right Grant
- 2000-12-22 IL IL15035000A patent/IL150350A0/xx unknown
- 2000-12-22 EP EP03027034A patent/EP1419773B1/en not_active Expired - Lifetime
- 2000-12-22 NZ NZ531643A patent/NZ531643A/en not_active IP Right Cessation
- 2000-12-22 KR KR1020027008066A patent/KR100771287B1/ko not_active IP Right Cessation
-
2002
- 2002-06-14 ZA ZA200204813A patent/ZA200204813B/xx unknown
- 2002-06-17 NO NO20022879A patent/NO323329B1/no not_active IP Right Cessation
- 2002-06-19 BG BG106845A patent/BG65698B1/bg unknown
- 2002-06-20 HR HR20020539A patent/HRP20020539B1/xx not_active IP Right Cessation
- 2002-06-20 IL IL150350A patent/IL150350A/en not_active IP Right Cessation
-
2003
- 2003-09-09 HK HK03106410.6A patent/HK1054228B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9904723D0 (sv) | New modulators of dopamine neurotransmission II | |
MXPA02006320A (es) | Nuevos moduladores de neurotransmision de dopamina. | |
HRP20000445B1 (en) | Aryl fused azapolycyclic compounds | |
NO961655L (no) | Visse sammensmeltede pyrrolkarboksanilider; en ny klasse GABA-hjernereseptorligander | |
HRP20070421T3 (en) | Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics | |
NO20001402L (no) | Substituerte kromanderivater | |
MXPA01004854A (es) | Nuevos compuestos de piperazina y piperidina. | |
YU40998A (sh) | Derivati supstituisanog 1,2,3,4-tetrahidronaftalina | |
RS50289B (sr) | Novi razgranati supstituisani amino derivati od 3-amino-1- fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže | |
ATE449071T1 (de) | Neue substituierte piperidine als modulatoren der dopamin neurotransmission | |
HUP0204278A2 (hu) | Nem peptid szubsztituált benzotiazepinszármazékok, mint vazopresszin antagonisták, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
NO941830L (no) | Karboksamid-derivater, deres fremstilling og anvendelse som terapeutika | |
AR023572A1 (es) | Derivados de tetrahidroisoquinolinil-indol para el tratamiento de la depresion y composicion farmaceutica que los comprende |